| Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial J Yin, J Yuan, Y Li, Y Fang, R Wang, H Jiao, H Tang, S Zhang, S Lin, F Su, ... Nature Medicine 29 (8), 2068-2078, 2023 | 33 | 2023 |
| Fibroblast growth factor 10 attenuates chronic obstructive pulmonary disease by protecting against glycocalyx impairment and endothelial apoptosis T Jiang, W Hu, S Zhang, C Ren, S Lin, Z Zhou, H Wu, J Yin, L Tan Respiratory Research 23 (1), 269, 2022 | 12 | 2022 |
| Which will carry more weight when CTR> 0.5, solid component size, CTR, tumor size or SUVmax? S Zhang, D Lin, Y Yu, Q Cao, G Liu, D Jiang, H Wang, Y Fang, Y Shen, ... Lung Cancer 164, 14-22, 2022 | 7 | 2022 |
| Development and Validation of PET/CT-Based Nomogram for Preoperative Prediction of Lymph Node Status in Esophageal Squamous Cell Carcinoma S Zhang, L Sun, D Cai, G Liu, D Jiang, J Yin, Y Fang, H Wang, Y Shen, ... Annals of Surgical Oncology 30 (12), 7452-7460, 2023 | 4 | 2023 |
| Neoadjuvant therapy with immunoagent (nivolumab) or placebo plus chemotherapy followed by surgery and adjuvant treatment in subjects with resectable esophageal squamous cell … J Yin, S Lin, Y Fang, H Jiao, Z Chen, H Tang, J Gu, S Zhang, L Sun, Y Li, ... Journal of Thoracic Disease 15 (2), 718, 2023 | 4 | 2023 |
| Publisher correction: neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1B trial J Yin, J Yuan, Y Li, Y Fang, R Wang, H Jiao, H Tang, S Zhang, S Lin, F Su, ... nature medicine 29 (9), 2376, 2023 | 3 | 2023 |
| Perioperative outcomes and survival after neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma X Yang, H Yin, S Zhang, T Jiang, J Gu, H Jiao, H Wang, F Liang, S Xu, ... The Journal of Thoracic and Cardiovascular Surgery 169 (1), 289-300. e6, 2025 | 2 | 2025 |
| The Single Nucleotide Polymorphisms of AP1S1 Are Associated with Risk of Esophageal Squamous Cell Carcinoma in Chinese Population F Su, Y Fang, J Yu, T Jiang, S Lin, S Zhang, L Lv, T Long, H Pan, J Qi, ... Pharmacogenomics and Personalized Medicine, 235-247, 2022 | 2 | 2022 |
| PPP1r18 promotes tumor progression in esophageal squamous cell carcinoma by regulating the calcineurin-mediated ERK pathway C Ren, L Wu, S Zhang, K Qi, Y Zhang, J Xu, Y Ruan, M Feng Carcinogenesis 45 (9), 673-684, 2024 | 1 | 2024 |
| SENP2 promotes ESCC proliferation through SETDB1 deSUMOylation and enhanced fatty acid metabolism L Sun, K Ma, S Zhang, J Gu, H Wang, L Tan Heliyon 10 (13), 2024 | 1 | 2024 |
| Telocytes protect against lung tissue fibrosis through hexokinase 2‐dependent pathway by secreting hepatocyte growth factor S Zhang, L Sun, B Chen, S Lin, J Gu, L Tan, M Lin Clinical and Experimental Pharmacology and Physiology 50 (12), 964-972, 2023 | 1 | 2023 |
| SENP1 Promotes Caspase-11 Inflammasome Activation and Aggravates Inflammatory Response in Murine Acute Lung Injury Induced by Lipopolysaccharide M Du, W Wang, S Zhang, J Gu, C Zhang, H Zhang Frontiers in Bioscience-Landmark 29 (11), 397, 2024 | | 2024 |
| 458. THORACOSCOPY VERSUS ENDOSCOPY IN THE TREATMENT OF ESOPHAGEAL LEIOMYOMA: A SINGLE-CENTER RETROSPECTIVE STUDY S Zhang, Z Geng, X Yang, C Ren, P Zhou, L Tan Diseases of the Esophagus 37 (Supplement_1), doae057. 205, 2024 | | 2024 |
| Suppression of SENP3 enhances macrophage alternative activation by mediating IRF4 de-SUMOylation in ESCC progression S Zhang, J Gu, W Wang, L Sun, T Jiang, X Yang, J Yin, M Lin, D Lin, ... Cell Communication and Signaling 22 (1), 395, 2024 | | 2024 |
| Suppressing SENP1 inhibits esophageal squamous carcinoma cell growth via SIRT6 SUMOylation J Gu, S Zhang, D Lin, W Wang, J Cheng, Q Zheng, H Wang, L Tan Cellular Oncology, 1-15, 2024 | | 2024 |
| Association of LAMA1 Single‐Nucleotide Polymorphisms with Risk of Esophageal Squamous Cell Carcinoma among the Eastern Chinese Population S Zhang, Y Fang, F Su, T Jiang, J Yu, S Lin, L Lv, T Long, H Pan, J Qi, ... Journal of Oncology 2023 (1), 6922909, 2023 | | 2023 |
